AKT1 and central nervous system cancer: Similarly in established (U251MG) or primary human glioma cells, NLGN3-induced Akt-mTORC1 and Erk-MAPK activation was inhibited by Gαi1/3 shRNA, but enhanced with ectopic Gαi1/3 overexpression.